About INTENSITY THERAPEUTICS, INC.
Intensity Therapeutics is a biotechnology company focused on developing novel intratumoral delivery technologies to treat cancer by killing tumor cells and activating systemic immune responses. Their lead product, INT230-6, is designed to improve survival rates in patients with metastatic and relapsed cancers.
Intratumoral delivery of therapeutic agentsDevelopment of DfuseRx℠, a proprietary penetration enhancer platform technologyInduction of localized cell death and systemic immune responseClinical trial execution for relapsed and refractory solid tumor patients
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to INTENSITY THERAPEUTICS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.